JP2024537394A5 - - Google Patents
Info
- Publication number
- JP2024537394A5 JP2024537394A5 JP2024522487A JP2024522487A JP2024537394A5 JP 2024537394 A5 JP2024537394 A5 JP 2024537394A5 JP 2024522487 A JP2024522487 A JP 2024522487A JP 2024522487 A JP2024522487 A JP 2024522487A JP 2024537394 A5 JP2024537394 A5 JP 2024537394A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- diazepine
- thieno
- triazolo
- cpd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021123848 | 2021-10-14 | ||
| CNPCT/CN2021/123848 | 2021-10-14 | ||
| CNPCT/CN2021/133363 | 2021-11-26 | ||
| CN2021133363 | 2021-11-26 | ||
| PCT/CN2022/125080 WO2023061440A1 (en) | 2021-10-14 | 2022-10-13 | Modified proteins and protein degraders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024537394A JP2024537394A (ja) | 2024-10-10 |
| JP2024537394A5 true JP2024537394A5 (cg-RX-API-DMAC7.html) | 2025-10-21 |
Family
ID=85987275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522487A Pending JP2024537394A (ja) | 2021-10-14 | 2022-10-13 | 修飾タンパク質およびタンパク質分解剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250235543A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4416145A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024537394A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118451078A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022362494A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3234615A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL312013A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024004525A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023061440A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3217792A1 (en) | 2021-05-07 | 2022-11-10 | Kymera Therapeutics, Inc | Cdk2 degraders and uses thereof |
| WO2024072794A1 (en) * | 2022-09-26 | 2024-04-04 | Rectify Pharmaceuticals, Inc. | Pyridine carboxamide compounds and their use in treating medical conditions |
| CN121005703A (zh) * | 2024-05-24 | 2025-11-25 | 中国科学院广州生物医药与健康研究院 | 一种酰胺吲嗪类化合物及其制备方法和应用 |
| WO2026107421A1 (en) * | 2024-11-18 | 2026-05-21 | Bristol-Myers Squibb Company | 1 h-benzo[d]imidazole derivatives as camk2 inhibitors for the treatment of heart failure |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201522337A (zh) * | 2013-03-12 | 2015-06-16 | Arqule Inc | 經取代之三環吡唑並-嘧啶化合物類 |
| WO2017185031A1 (en) * | 2016-04-22 | 2017-10-26 | Dana-Farber Cancer Institute, Inc. | Degradation of cyclin-dependent kinase 4/6 (cdk4/6) by conjugation of cdk4/6 inhibitors with e3 ligase ligand and methods of use |
| CA3045037A1 (en) * | 2016-12-08 | 2018-06-14 | Icahn School Of Medicine At Mount Sinai | Compositions and methods for treating cdk4/6-mediated cancer |
| US11191741B2 (en) * | 2016-12-24 | 2021-12-07 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide |
| CA3103185A1 (en) * | 2018-06-13 | 2019-12-19 | Amphista Therapeutics Ltd | Bifunctional molecules for targeting rpn11 |
| WO2020092662A1 (en) * | 2018-11-02 | 2020-05-07 | The Wistar Institute Of Anatomy And Biology | Proteolysis-targeting chimeras |
| EA202192260A1 (ru) * | 2019-02-15 | 2021-12-17 | Инсайт Корпорейшн | Биомаркеры циклин-зависимой киназы 2 и их применение |
| CN113646002A (zh) * | 2019-02-27 | 2021-11-12 | 上海睿跃生物科技有限公司 | 环amp反应元件结合蛋白(cbp)和/或300kda腺病毒e1a结合蛋白(p300)降解化合物和使用方法 |
| WO2020206608A1 (en) * | 2019-04-09 | 2020-10-15 | Ranok Therapeutics (Hangzhou) Co., Ltd. | Methods and compositions for targeted protein degradation |
| JP2022529700A (ja) * | 2019-04-23 | 2022-06-23 | ダナ-ファーバー キャンサー インスティテュート,インコーポレイテッド | サイクリン依存性キナーゼ12(cdk12)の分解剤およびその使用 |
| CN112409376A (zh) * | 2019-08-20 | 2021-02-26 | 华东师范大学 | 一种基于dcaf15的蛋白降解靶向嵌合体及其制备方法和应用 |
| WO2021061151A1 (en) * | 2019-09-27 | 2021-04-01 | Romark Laboratories L.C. | Screening for anti-hepatitis b compounds |
| CN114502534A (zh) * | 2019-09-30 | 2022-05-13 | 协和麒麟株式会社 | Bet降解剂 |
| WO2021239117A1 (en) * | 2020-05-28 | 2021-12-02 | Cullgen (Shanghai) , Inc. | Modified proteins and protein degraders |
| CN116507333B (zh) * | 2020-08-27 | 2025-05-09 | 上海睿跃生物科技有限公司 | 环amp反应元件结合蛋白(cbp)和/或300kda腺病毒e1a结合蛋白(p300)降解化合物和使用方法 |
| TW202423914A (zh) * | 2022-08-19 | 2024-06-16 | 美商凱麥拉醫療公司 | Cdk2降解劑及其用途 |
| US20240174665A1 (en) * | 2022-08-19 | 2024-05-30 | Kymera Therapeutics, Inc. | Cdk2 inhibitors and uses thereof |
-
2022
- 2022-10-13 AU AU2022362494A patent/AU2022362494A1/en active Pending
- 2022-10-13 CN CN202280082680.9A patent/CN118451078A/zh active Pending
- 2022-10-13 US US18/700,898 patent/US20250235543A1/en active Pending
- 2022-10-13 EP EP22880376.3A patent/EP4416145A4/en active Pending
- 2022-10-13 IL IL312013A patent/IL312013A/en unknown
- 2022-10-13 MX MX2024004525A patent/MX2024004525A/es unknown
- 2022-10-13 CA CA3234615A patent/CA3234615A1/en active Pending
- 2022-10-13 WO PCT/CN2022/125080 patent/WO2023061440A1/en not_active Ceased
- 2022-10-13 JP JP2024522487A patent/JP2024537394A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025512474A5 (cg-RX-API-DMAC7.html) | ||
| RU2472797C2 (ru) | ПРОИЗВОДНЫЕ 2-[(2-(ФЕНИЛАМИНО)-1Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)АМИНО]БЕНЗАМИДА В КАЧЕСТВЕ ИНГИБИТОРОВ IGF-1R ДЛЯ ЛЕЧЕНИЯ РАКА | |
| RU2477723C2 (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
| JP2015511629A5 (cg-RX-API-DMAC7.html) | ||
| JP2013510122A5 (cg-RX-API-DMAC7.html) | ||
| RU2001114978A (ru) | N-ариламиды антраниловой кислоты и тиоантраниловой кислоты | |
| JP2016506387A5 (cg-RX-API-DMAC7.html) | ||
| RU2003114740A (ru) | Азотсодержащие ароматические производные | |
| RU2019136279A (ru) | C5 -Анилинохиназолиновые соединения и их использование в лечении рака | |
| JP2022549510A5 (cg-RX-API-DMAC7.html) | ||
| RU2008100606A (ru) | Ингибиторы сфингозинкиназы | |
| JP2019521111A5 (cg-RX-API-DMAC7.html) | ||
| RU2006146632A (ru) | Производные хиназолинона, полезные в качестве ванилоидных антагонистов | |
| RU2007141892A (ru) | 5-метил-1-(замещенный фенил)-2-(1н)-пиридон для производства медикаментов для лечения фиброза в органах и тканях | |
| RU2007132161A (ru) | Замещенные ариламины и их применение в качестве модуляторов 5-ht6-рецептора | |
| RU2011152891A (ru) | Диарилгидантоины | |
| JP2001526276A5 (cg-RX-API-DMAC7.html) | ||
| JP2008535871A5 (cg-RX-API-DMAC7.html) | ||
| RU2004130488A (ru) | Пиримидиновые производные | |
| CA2660529A1 (en) | Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders | |
| JP2011509309A5 (cg-RX-API-DMAC7.html) | ||
| RU2007148217A (ru) | Получение производных n-фенил-2-пиримидинамина | |
| JP2014502979A5 (cg-RX-API-DMAC7.html) | ||
| EA200300424A1 (ru) | Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов | |
| RU2009118254A (ru) | Фенилацетамиды в качестве ингибиторов протеинкиназ |